Franz Oesch

24.5k total citations · 2 hit papers
576 papers, 19.6k citations indexed

About

Franz Oesch is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Franz Oesch has authored 576 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 232 papers in Molecular Biology, 206 papers in Pharmacology and 162 papers in Cancer Research. Recurrent topics in Franz Oesch's work include Pharmacogenetics and Drug Metabolism (198 papers), Eicosanoids and Hypertension Pharmacology (134 papers) and Carcinogens and Genotoxicity Assessment (133 papers). Franz Oesch is often cited by papers focused on Pharmacogenetics and Drug Metabolism (198 papers), Eicosanoids and Hypertension Pharmacology (134 papers) and Carcinogens and Genotoxicity Assessment (133 papers). Franz Oesch collaborates with scholars based in Germany, United States and Switzerland. Franz Oesch's co-authors include Hansruedi Glatt, Michael Arand, Karl L. Platt, Jan G. Hengstler, P. Bentley, Thomas Friedberg, Jeanette M. Daly, Thomas Efferth, D. M. JERINA and Robert Landsiedel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Franz Oesch

567 papers receiving 18.6k citations

Hit Papers

Mammalian Epoxide Hydrase... 1971 2026 1989 2007 1973 1971 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Franz Oesch 8.2k 5.9k 4.5k 4.0k 2.6k 576 19.6k
Allan H. Conney 11.7k 1.4× 8.7k 1.5× 6.2k 1.4× 2.4k 0.6× 4.2k 1.6× 373 29.2k
C. Roland Wolf 12.8k 1.6× 9.1k 1.5× 3.1k 0.7× 2.1k 0.5× 5.8k 2.2× 460 24.8k
Tsutomu Shimada 6.7k 0.8× 11.0k 1.9× 3.6k 0.8× 1.6k 0.4× 5.0k 1.9× 317 20.2k
John D. Hayes 27.9k 3.4× 2.9k 0.5× 3.2k 0.7× 2.2k 0.6× 2.1k 0.8× 262 37.1k
Bengt Mannervik 19.0k 2.3× 4.0k 0.7× 1.1k 0.3× 2.9k 0.7× 1.6k 0.6× 591 30.6k
Arthur I. Cederbaum 6.7k 0.8× 4.0k 0.7× 980 0.2× 3.4k 0.9× 1.3k 0.5× 351 19.1k
Peter J. O’Brien 8.3k 1.0× 2.3k 0.4× 1.3k 0.3× 1.5k 0.4× 1.2k 0.4× 403 22.4k
Janardan K. Reddy 15.2k 1.8× 1.9k 0.3× 3.3k 0.7× 2.2k 0.5× 3.4k 1.3× 333 22.4k
Neil Kaplowitz 8.4k 1.0× 9.2k 1.6× 1.0k 0.2× 3.7k 0.9× 4.4k 1.7× 314 30.6k
Emmanuel Farber 7.3k 0.9× 1.8k 0.3× 3.8k 0.9× 1.7k 0.4× 2.9k 1.1× 280 15.4k

Countries citing papers authored by Franz Oesch

Since Specialization
Citations

This map shows the geographic impact of Franz Oesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Oesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Oesch more than expected).

Fields of papers citing papers by Franz Oesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Oesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Oesch. The network helps show where Franz Oesch may publish in the future.

Co-authorship network of co-authors of Franz Oesch

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Oesch. A scholar is included among the top collaborators of Franz Oesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Oesch. Franz Oesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffer, Ilka B., Susanne Gebhard, Berno Tanner, et al.. (2006). Dephosphorylation of p‐ERK1/2 in relation to tumor remission after HER‐2 and Raf1 blocking therapy in a conditional mouse tumor model. Molecular Carcinogenesis. 45(5). 302–308. 11 indexed citations
2.
Micke, Patrick, Maryam Basrai, Andreas Faldum, et al.. (2003). Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.. PubMed. 9(1). 188–94. 124 indexed citations
3.
Hengstler, Jan G., Henryk Pilch, M Schmidt, et al.. (2001). Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. International Journal of Cancer. 95(2). 121–127. 50 indexed citations
4.
Hengstler, Jan G., Nadja Dornhöfer, Rolf Meinert, et al.. (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. PubMed. 59(13). 3206–14. 87 indexed citations
5.
Oesch, Franz, Barbara Oesch‐Bartlomowicz, J. F. Arens, et al.. (1994). Mechanism-based predictions of interactions.. Environmental Health Perspectives. 102(suppl 9). 5–9. 8 indexed citations
6.
Wieser, Raimund & Franz Oesch. (1992). Contact-Inhibition of Growth by Complex Carbohydrates.. Trends in Glycoscience and Glycotechnology. 4(16). 160–167. 5 indexed citations
7.
Thomas, Helmut, et al.. (1990). Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA.. Environmental Health Perspectives. 88. 49–55. 10 indexed citations
8.
Steinberg, Pablo, et al.. (1990). Rat liver endothelial and Kupffer cell-mediated mutagenicity of polycyclic aromatic hydrocarbons and aflatoxin B1.. Environmental Health Perspectives. 88. 71–76. 13 indexed citations
9.
Wieser, Raimund, et al.. (1990). Growth control in mammalian cells by cell-cell contacts.. Environmental Health Perspectives. 88. 251–253. 25 indexed citations
10.
Klein, Jochen, Karin Post, Detlev Suckau, et al.. (1990). Mass spectrometric peptide mapping analysis and structural characterization of dihydrodiol dehydrogenase isoenzymes.. Environmental Health Perspectives. 88. 57–62. 10 indexed citations
11.
Platt, Karl L., et al.. (1990). Stereoselective metabolism of dibenz(a,h)anthracene to trans-dihydrodiols and their activation to bacterial mutagens.. Environmental Health Perspectives. 88. 37–41. 10 indexed citations
12.
Doehmer, Johannes, A. Seidel, Franz Oesch, & Hansruedi Glatt. (1990). Genetically engineered V79 Chinese hamster cells metabolically activate the cytostatic drugs cyclophosphamide and ifosfamide.. Environmental Health Perspectives. 88. 63–65. 25 indexed citations
13.
Friedberg, Thomas, et al.. (1990). Studies of the expression of the cytochrome P450IA, P450IIB, and P450IIC gene family in extrahepatic and hepatic tissues.. Environmental Health Perspectives. 88. 67–70. 10 indexed citations
14.
Glatt, Hansruedi, Reinhard Henschler, David H. Phillips, et al.. (1990). Sulfotransferase-mediated chlorination of 1-hydroxymethylpyrene to a mutagen capable of penetrating indicator cells.. Environmental Health Perspectives. 88. 43–48. 42 indexed citations
15.
Glatt, Hansruedi, Glenn A. Berchtold, Gabriele Ludewig, et al.. (1989). Multiple activation pathways of benzene leading to products with varying genotoxic characteristics.. Environmental Health Perspectives. 82. 81–89. 84 indexed citations
16.
Steinberg, Pablo, et al.. (1987). Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.. Molecular Pharmacology. 32(4). 463–470. 57 indexed citations
18.
Guenthner, Thomas M., et al.. (1981). Differences in stability and localization of rabbit liver epoxide hydrolase activities towards different substrates. Cellular and Molecular Life Sciences. 37(6). 676. 2 indexed citations
19.
Oesch, Franz. (1977). [Importance of various enzymes in the control of mutagenic and carcinogenic hydrocarbons].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(11). 563–73. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026